More News of Interest

Senseonics to Present at the B. Riley & Co. Institutional Investor Conference

Senseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the company will be participating in the upcoming B. Riley & Co. Institutional Investor Conference in Santa Monica, CA.

Senseonics’ management is scheduled to present on Thursday, May 25, 2017 at 11:30am PT. Interested parties may access a webcast of the presentation on the “Investor Relations” section of the company’s website.

Latest Posts


Don't Miss

Stay on top - Get Medical Device News Magazine daily news in your inbox

Enter your email address:

Delivered by FeedBurner